VC fund manager AmorChem has launched AmorChem II, a $44.2m seed-stage life sciences fund backed by Merck & Co.

Digital+ Partners' Digital Growth Fund I vehicle will focus on fintech and industrial technology businesses in Germany, Austria and Switzerland.

Cisco Investments, Shell Technology Ventures and ABB Ventures all came on board for the aerial data provider's series C round, taking its total funding to $61m.

China Electronics Corporation Data led the doctor-focused social media app's latest round, which included existing investor Tencent.

Alphabet, Takeda, ShangPharma and Amgen were among the investors in gene and cell therapy startup Obsidian Therapeutics' $49.5m series A round.

Quanterix, a digital immunoassay developer backed by BioMerieux and Stratec, has raised $64.1m in its initial public offering.

The Advance Publications and IGM-backed fashion e-commerce platform has now raised $297m since it was founded in 2011.

ING-backed customer data software developer NGData will use the series C proceeds to accelerate international growth.

Queen's University spinout Fusion Antibodies is targeting $7.4m in proceeds in an IPO that will provide an exit to Qubis and Invest NI.